Lantheus Medcl Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LANTHEUS MEDCL, and when can generic versions of LANTHEUS MEDCL drugs launch?
LANTHEUS MEDCL has nine approved drugs.
There are ten US patents protecting LANTHEUS MEDCL drugs.
There are sixty-nine patent family members on LANTHEUS MEDCL drugs in seventeen countries and eight supplementary protection certificates in five countries.
Summary for Lantheus Medcl
International Patents: | 69 |
US Patents: | 10 |
Tradenames: | 10 |
Ingredients: | 8 |
NDAs: | 9 |
Drugs and US Patents for Lantheus Medcl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lantheus Medcl | TECHNELITE | technetium tc-99m sodium pertechnetate generator | SOLUTION;INTRAVENOUS | 017771-002 | Feb 12, 2014 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Lantheus Medcl | DEFINITY RT | perflutren | INJECTABLE;INTRAVENOUS | 021064-002 | Nov 17, 2020 | RX | Yes | Yes | 10,583,207 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Lantheus Medcl | NEUROLITE | technetium tc-99m bicisate kit | INJECTABLE;INJECTION | 020256-001 | Nov 23, 1994 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Lantheus Medcl | DEFINITY | perflutren | INJECTABLE;INTRAVENOUS | 021064-001 | Jul 31, 2001 | RX | Yes | Yes | 11,266,750 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Lantheus Medcl
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Lantheus Medcl | ABLAVAR | gadofosveset trisodium | SOLUTION;INTRAVENOUS | 021711-002 | Dec 22, 2008 | 8,394,356 | ⤷ Try a Trial |
Lantheus Medcl | MIRALUMA | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 019785-003 | May 23, 1997 | 4,885,100 | ⤷ Try a Trial |
Lantheus Medcl | ABLAVAR | gadofosveset trisodium | SOLUTION;INTRAVENOUS | 021711-001 | Dec 22, 2008 | 5,362,475 | ⤷ Try a Trial |
Lantheus Medcl | CARDIOLITE | technetium tc-99m sestamibi kit | INJECTABLE;INJECTION | 019785-001 | Dec 21, 1990 | 4,894,445 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Lantheus Medcl Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
New Zealand | 733010 | ⤷ Try a Trial |
Taiwan | 202222260 | ⤷ Try a Trial |
Mexico | 2022011694 | ⤷ Try a Trial |
Japan | 2019515936 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Lantheus Medcl Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0806968 | PA2007003,C0806968 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: GADOFOSVESETUM TRINATRICUM; REGISTRATION NO/DATE: EU/1/05/313/001, 2005 10 05 EU/1/05/313/002, 2005 10 05 EU/1/05/313/003, 2005 10 05 EU/1/05/313/004, 2005 10 05 EU/1/05/313/005, 2005 10 05 EU/1/05/313/006, 2006 10 05 EU/1/05/313/007, 2005 10 05 EU/1/05/313/008, 2005 10 05 EU/1/05/313/00 2005100 |
0806968 | 07C0028 | France | ⤷ Try a Trial | PRODUCT NAME: GADOFOSVESET TRISODIQUE; REGISTRATION NO/DATE: EU/1/05/313/001-009 20051003 |
0806968 | PA2007003 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: GADOFOSVESETUM TRINATRICUM; REG NO/DATE: EU/1/05/313/001-009 20051005 |
0712293 | 0790017-8 | Sweden | ⤷ Try a Trial | PRODUCT NAME: LIPIDMIKROSFAERER INNEHALLANDE PERFLUTREN; REG. NO/DATE: EU/1/06/361/001 20060920 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.